Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Daily News

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Yael L. Maxwell

March 13, 2025

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Yael L. Maxwell

January 10, 2024

News Daily News

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Yael L. Maxwell

September 05, 2023

News Daily News

Before and After PCI, Women Have Poorer Health Status Than Men

L.A. McKeown

January 28, 2022

News Daily News

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

L.A. McKeown

September 07, 2021

Crushing Prasugrel Tabs Ups Platelet Inhibition Following Primary PCI

News Daily News

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Yael L. Maxwell

June 22, 2021

News Daily News

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

L.A. McKeown

April 05, 2021

News Daily News

Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate

L.A. McKeown

February 26, 2021

News Daily News

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

Todd Neale

December 16, 2020

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Todd Neale

October 09, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

L.A. McKeown

June 29, 2020

Advertisement

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Before and After PCI, Women Have Poorer Health Status Than Men

Lidocaine Less Likely Than Fentanyl to Blunt P2Y12 Inhibitors in the Cath Lab

Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

More Women Than Men Develop HF or Die After STEMI

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content